Suppr超能文献

铜绿假单胞菌蛋白酶IV可降解表面活性蛋白,并抑制表面活性物质的宿主防御及生物物理功能。

Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions.

作者信息

Malloy Jaret L, Veldhuizen Ruud A W, Thibodeaux Brett A, O'Callaghan Richard J, Wright Jo Rae

机构信息

Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2005 Feb;288(2):L409-18. doi: 10.1152/ajplung.00322.2004. Epub 2004 Oct 29.

Abstract

Pulmonary surfactant has two distinct functions within the lung: reduction of surface tension at the air-liquid interface and participation in innate host defense. Both functions are dependent on surfactant-associated proteins. Pseudomonas aeruginosa is primarily responsible for respiratory dysfunction and death in cystic fibrosis patients and is also a leading pathogen in nosocomial pneumonia. P. aeruginosa secretes a number of proteases that contribute to its virulence. We hypothesized that P. aeruginosa protease IV degrades surfactant proteins and results in a reduction in pulmonary surfactant host defense and biophysical functions. Protease IV was isolated from cultured supernatant of P. aeruginosa by gel chromatography. Incubation of cell-free bronchoalveolar lavage fluid with protease IV resulted in degradation of surfactant proteins (SP)-A, -D, and -B. SPs were degraded in a time- and dose-dependent fashion by protease IV, and degradation was inhibited by the trypsin-like serine protease inhibitor Nalpha-p-tosyl-L-lysine-chloromethyl ketone (TLCK). Degradation by protease IV inhibited SP-A- and SP-D-mediated bacterial aggregation and uptake by macrophages. Surfactant treated with protease IV was unable to reduce surface tension as effectively as untreated surfactant, and this effect was inhibited by TLCK. We speculate that protease IV may be an important contributing factor to the development and propagation of acute lung injury associated with P. aeruginosa via loss of surfactant function within the lung.

摘要

肺表面活性物质在肺内有两种不同功能

降低气液界面的表面张力以及参与固有宿主防御。这两种功能均依赖于与表面活性物质相关的蛋白质。铜绿假单胞菌是囊性纤维化患者呼吸功能障碍和死亡的主要原因,也是医院获得性肺炎的主要病原体。铜绿假单胞菌分泌多种有助于其毒力的蛋白酶。我们推测铜绿假单胞菌蛋白酶IV会降解表面活性物质蛋白,导致肺表面活性物质的宿主防御和生物物理功能降低。通过凝胶色谱法从铜绿假单胞菌培养上清液中分离出蛋白酶IV。将无细胞支气管肺泡灌洗液与蛋白酶IV孵育导致表面活性物质蛋白(SP)-A、-D和-B降解。蛋白酶IV以时间和剂量依赖的方式降解SP,并且这种降解被胰蛋白酶样丝氨酸蛋白酶抑制剂Nα-对甲苯磺酰-L-赖氨酸氯甲基酮(TLCK)抑制。蛋白酶IV引起的降解抑制了SP-A和SP-D介导的细菌聚集以及巨噬细胞的摄取。用蛋白酶IV处理的表面活性物质降低表面张力的效果不如未处理的表面活性物质,并且这种效应被TLCK抑制。我们推测蛋白酶IV可能是通过肺内表面活性物质功能丧失而导致与铜绿假单胞菌相关的急性肺损伤发生和发展的一个重要因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验